Price
381.2
+3.23%52W Range
Market Cap
₹4,153.76 Cr
Traded: ₹6.81 Cr (0.16%) 0.0x
Free Float: ₹1,087.45 Cr (0.63% of FF traded)
Volume · 60D trend
1.8 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | -- | -- | -- | -- | -- |
| ROE | -- | -- | -- | -- | -- | -- |
| Return | +48.0% | +45.0% | +49.0% | +1.0% | -- | Stable |
| Profit | -- | -- | -- | -- | -- | -- |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 44 | 44 | 43 | 42 | 36 | 38 | 40 | 35 | 39 | 42 | 39 | 40 | 50 | 28 |
| Expenses | 23 | 25 | 22 | 21 | 22 | 22 | 21 | 19 | 20 | 21 | 21 | 23 | 26 | 13 |
| Operating Profit | 21 | 19 | 21 | 21 | 14 | 16 | 19 | 15 | 19 | 21 | 18 | 17 | 24 | 14 |
| OPM % | 48.0% | 44.0% | 49.0% | 49.0% | 39.0% | 42.0% | 48.0% | 44.0% | 48.0% | 50.0% | 46.0% | 42.0% | 47.0% | 52.0% |
| Other Income | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 |
| Interest | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 4 | 4 | 4 | 3 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 15 | 14 | 17 | 19 | 12 | 16 | 17 | 14 | 18 | 21 | 18 | 17 | 24 | 16 |
| Tax % | 27.0% | 24.0% | 26.0% | 24.0% | 25.0% | 25.0% | 25.0% | 26.0% | 26.0% | 24.0% | 26.0% | 26.0% | 26.0% | 25.0% |
| Net Profit | 11 | 11 | 12 | 14 | 9 | 12 | 13 | 11 | 13 | 16 | 13 | 13 | 18 | 12 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 1.0 | 1.0 | 1.1 | 1.3 | 0.8 | 1.1 | 1.2 | 1.0 | 1.2 | 1.5 | 1.2 | 1.1 | 1.6 | 1.1 |
| Sales Growth (YoY) | 22.2% | 15.8% | 7.5% | 20.0% | -7.7% | -9.5% | 2.6% | -12.5% | -22.0% | 50.0% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 0.0% | 2.3% | 2.4% | 16.7% | -5.3% | -5.0% | 14.3% | -10.3% | -7.1% | 7.7% | -2.5% | -20.0% | 78.6% | -- |
| OP Growth (YoY) | 50.0% | 18.8% | 10.5% | 40.0% | -26.3% | -23.8% | 5.6% | -11.8% | -20.8% | 50.0% | -- | -- | -- | -- |
| OP Growth (QoQ) | 10.5% | -9.5% | 0.0% | 50.0% | -12.5% | -15.8% | 26.7% | -21.1% | -9.5% | 16.7% | 5.9% | -29.2% | 71.4% | -- |
| Profit Growth (YoY) | -- | -9.3% | -3.9% | 34.9% | -31.6% | -24.5% | -0.3% | -15.7% | -25.3% | 35.9% | 32.6% | -32.9% | -0.3% | 19.4% |
| EPS Growth (YoY) | 22.9% | -9.1% | -4.2% | 35.0% | -31.4% | -24.7% | 0.0% | -15.7% | -25.8% | 36.5% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 2.0% | -12.3% | -13.0% | 57.8% | -24.6% | -7.6% | 22.7% | -19.8% | -17.1% | 22.7% | 3.5% | -29.4% | 52.3% | -- |
| OP Margin | 47.7% | 43.2% | 48.8% | 50.0% | 38.9% | 42.1% | 47.5% | 42.9% | 48.7% | 50.0% | 46.1% | 42.5% | 48.0% | 50.0% |
| Net Margin | 25.0% | 25.0% | 27.9% | 33.3% | 25.0% | 31.6% | 32.5% | 31.4% | 33.3% | 38.1% | 33.3% | 32.5% | 36.0% | 42.9% |
| Material Cost % | -- | 8.0% | 13.4% | 12.7% | 18.5% | 16.5% | 17.7% | 15.1% | 15.6% | 19.7% | 17.9% | 20.1% | 27.2% | 7.2% |
| Employee Cost % | -- | 8.6% | 11.0% | 11.4% | 8.7% | 8.3% | 7.6% | 9.4% | 8.2% | 9.9% | 10.0% | 9.3% | 4.2% | 7.7% |
| P/S | 24.01 | 23.90 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 85.28 | 84.56 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | -- | 13.69 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Please refer to the attachment.
Please refer to the attachment.
Please refer to the attachment.
Please refer to the attachment.
Please refer to the attachment
Please refer to the outcome / proceedings of EGM held on 22.08.2026
Earnings Call Transcript
Please refer to our submission of Call Recordings of the investor/analyst Conference Call held on Monday, August 10, 2026 (IST).
Please refer to the copies of newspaper articles published for the un-audited financial results for the quarter ended 30.06.2026
Please refer to the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June ,2026
Please refer to our investors presentation for the quarter ended 30.06.2026
Please refer to the outcome of the Board meeting held on 07.08.2026
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachin D Patel
Please refer to the attachment.
Please refer to our copies of Newspaper Publication dated 24.07.2026 for Postal Ballot.
Please refer to the Notice of Postal Ballot 22.07.2026
The Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 ....
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 21, 2026 for Pharmaceutical ....
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Themis Medicare Ltd
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Pharmaceutical ....
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 16, 2026 for Pharmaceutical Business ....
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 16, 2026 for Themis Medicare Ltd
Intimation of revision in credit rating
The Exchange has received the updates on revised disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) ....
Please refer to our intimation under Regulation 30 (LODR) -Updates on Arbitration matter.
Please refer to the attachment.
Please refer to the attachment.
Please refer to our Postal Ballot Outcome dated 8th July, 2026
Please refer to our Scrutinizer''s Report and Voting Results of Postal Ballot dated 8th July, 2026.
Please refer to attached Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 03, 2026 for Pharmaceutical Business ....
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on July ....
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachin D Patel
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachin D Patel
Please refer to the attachment.
Please refer to the attachment.
Intimation of closure of Trading Window
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Please refer to the attachmnet
The Board Meeting to be held on 19/06/2026 Stands Cancelled.
Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/06/2026 ,inter alia, to consider and approve the proposal for raising ....
Newspaper Publication of Postal Ballot Notice dated 6th June, 2026
Please refer to the attachment.
Please refer to the attachment.
Voting Results on Postal Ballot through e-voting and Scrutinizer''s Report dated 04th June, 2026.
Please refer to Voting Results and Scrutinizer''s Report on Postal Ballot dated 4th June, 2026
Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/06/2026 ,inter alia, to consider and approve the proposals for raising ....
Annual Secretarial Compliance Report for the financial year ended 31.03.2026
Annual Reports
15Credit Ratings
6Concalls
19Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Oct 2024
31 Oct 2024Jul 2024
31 Jul 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Jun 2022
30 Jun 2022Mar 2022
31 Mar 2022Nov 2021
30 Nov 2021Nov 2021
30 Nov 2021Sep 2021
30 Sept 2021Held by ETFs
1 ETFs hold GUJTHEM · sorted by weight
Held by Mutual Funds
3 schemes hold GUJTHEM · sorted by weight